Do Haleon plc ADR (NYSE: HLN) Fit In A Value Investing Philosophy?

Currently, there are 4.51B common shares owned by the public and among those 4.51B shares have been available to trade.

The company’s stock has a 5-day price change of 3.22% and 10.64% over the past three months. HLN shares are trading 17.71% year to date (YTD), with the 12-month market performance up to 32.12% higher. It has a 12-month low price of $8.24 and touched a high of $11.19 over the same period. HLN has an average intraday trading volume of 14.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.81%, 8.47%, and 12.34% respectively.

Institutional ownership of Haleon plc ADR (NYSE: HLN) shares accounts for 12.63% of the company’s 4.51B shares outstanding.

It has a market capitalization of $50.65B and a beta (3y monthly) value of 0.27. The stock’s trailing 12-month PE ratio is 27.96, while the earnings-per-share (ttm) stands at $0.40. The company has a PEG of 2.94 and a Quick Ratio of 0.78 with the debt-to-equity ratio at 0.63. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.56% over the week and 1.42% over the month.

Analysts forecast that Haleon plc ADR (HLN) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0.48 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to increase by 10.24%, and 9.26% over the next financial year. EPS should shrink at an annualized rate of 9.50% over the next five years, compared to 17.40% over the past 5-year period.

Looking at the support for the HLN, a number of firms have released research notes about the stock. BNP Paribas Exane stated their Outperform rating for the stock in a research note on May 27, 2025, with the firm’s price target at $13.40. Morgan Stanley coverage for the Haleon plc ADR (HLN) stock in a research note released on May 09, 2025 offered a Overweight rating with a price target of $11.25. Bernstein on their part issued Mkt Perform rating on January 08, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.